Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.

Current drug abuse reviews

Volumn 1, Issue 3, 2008, Pages 303-327

  Xi, Zheng Xiong ^a   Gardner, Eliot L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID CARRIER; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; AMPA RECEPTOR; CENTRAL STIMULANT AGENT; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ENDOCANNABINOID; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NARCOTIC ANTAGONIST; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; VESICULAR MONOAMINE TRANSPORTER;

ADDICTION; ANIMAL; BRAIN; COCAINE DEPENDENCE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; HUMAN; METABOLISM; PSYCHOLOGICAL ASPECT; REVIEW; TREATMENT OUTCOME;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE-RELATED DISORDERS; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DRUG EVALUATION, PRECLINICAL; ENDOCANNABINOIDS; EXCITATORY AMINO ACID AGONISTS; GABA AGONISTS; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; NARCOTIC ANTAGONISTS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; VESICULAR MONOAMINE TRANSPORT PROTEINS;

MLCS; MLOWN;

EID: 67349196145     PISSN: None     EISSN: 18744745     Source Type: Journal    
DOI: 10.2174/1874473710801030303     Document Type: Review

References (372)